Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olav Mella

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Scientific Reports|March 27, 2020
Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Asgeir Lande, Øystein Fluge, Elin B Strand, et al.
Brain, Behavior, and Immunity|March 23, 2022
Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk lociRiad Hajdarevic, Asgeir Lande, Jesper Mehlsen, et al.
Journal of Translational Medicine|July 7, 2025
SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitisBita Rostami-Afshari, Wesam Elremaly, Anita Franco, et al.
Journal of Translational Medicine|August 14, 2025
Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitisBita Rostami-Afshari, Wesam Elremaly, Anita Franco, et al.
Brain, Behavior, and Immunity|September 2, 2025
Killer cell immunoglobulin-like receptor (KIR) alleles suggested to be associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)Donia Jamal Ramadan, Katherine M Kichula, Sudan Tao, et al.
Cell Reports. Medicine|March 5, 2026
Charting the circulating proteome in ME/CFS using cross-system profiling to uncover mechanistic insightsAugust Hoel, Fredrik Hoel, Sissel Elisabeth Dyrstad, et al.
Brain, Behavior, and Immunity|August 17, 2021
Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II lociRiad Hajdarevic, Asgeir Lande, Ingrid Rekeland, et al.
Frontiers in Medicine|May 16, 2020
Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II StudyIngrid G Rekeland, Alexander Fosså, Asgeir Lande, et al.
JCI Insight|August 23, 2021
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndromeFredrik Hoel, August Hoel, Ina Kn Pettersen, et al.
Cancer|June 22, 2005
First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinomaAnneke M Westermann, Ellen L Jones, Baard-Christian Schem, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Scientific Reports|March 27, 2020
Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Asgeir Lande, Øystein Fluge, Elin B Strand, et al.
Brain, Behavior, and Immunity|March 23, 2022
Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk lociRiad Hajdarevic, Asgeir Lande, Jesper Mehlsen, et al.
Journal of Translational Medicine|July 7, 2025
SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitisBita Rostami-Afshari, Wesam Elremaly, Anita Franco, et al.
Journal of Translational Medicine|August 14, 2025
Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitisBita Rostami-Afshari, Wesam Elremaly, Anita Franco, et al.
Brain, Behavior, and Immunity|September 2, 2025
Killer cell immunoglobulin-like receptor (KIR) alleles suggested to be associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)Donia Jamal Ramadan, Katherine M Kichula, Sudan Tao, et al.
Cell Reports. Medicine|March 5, 2026
Charting the circulating proteome in ME/CFS using cross-system profiling to uncover mechanistic insightsAugust Hoel, Fredrik Hoel, Sissel Elisabeth Dyrstad, et al.
Brain, Behavior, and Immunity|August 17, 2021
Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II lociRiad Hajdarevic, Asgeir Lande, Ingrid Rekeland, et al.
Frontiers in Medicine|May 16, 2020
Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II StudyIngrid G Rekeland, Alexander Fosså, Asgeir Lande, et al.
JCI Insight|August 23, 2021
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndromeFredrik Hoel, August Hoel, Ina Kn Pettersen, et al.
Cancer|June 22, 2005
First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinomaAnneke M Westermann, Ellen L Jones, Baard-Christian Schem, et al.
Pageof 5